|
Volumn , Issue 615, 2003, Pages 1-6
|
Balancing safety, effectiveness, and public desire: the FDA and cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEW DRUG;
ADULT;
ARTICLE;
CHILD;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG LEGISLATION;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ORGANIZATION;
HUMAN;
LEGAL ASPECT;
NEOPLASM;
PATENT;
RESEARCH;
SAFETY;
UNITED STATES;
ADULT;
CHILD;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUGS, INVESTIGATIONAL;
HUMANS;
INTELLECTUAL PROPERTY;
LEGISLATION, DRUG;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASMS;
RESEARCH;
SAFETY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0038518711
PISSN: None
EISSN: 15586847
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|